Library Logo

A practical guide to designing phase II trials in oncology / (Record no. 207059)

000 -LEADER
fixed length control field 04657cam a2200925 i 4500
001 - CONTROL NUMBER
control field ocn861966489
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20171106082003.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 131030s2014 enk ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2013043516
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118763636 (ePub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118763637 (ePub)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118763629 (Adobe PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118763629 (Adobe PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781118570906 (hardback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118763612
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118763610
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1118570901
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781118570906
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781306546898
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1306546893
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier CHBIS
System control number 010259581
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier CHVBK
System control number 325944229
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 15581352
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DEBSZ
System control number 423179748
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 15906857
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier NZ1
System control number 16092524
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier GBVCP
System control number 813893275
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier DEBBG
System control number BV043396313
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)861966489
Canceled/invalid control number (OCoLC)927508965
-- (OCoLC)961619204
-- (OCoLC)962565629
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
Language of cataloging eng
Description conventions rda
Transcribing agency DLC
Modifying agency N$T
-- IDEBK
-- E7B
-- CUS
-- DG1
-- YDXCP
-- CDX
-- OCLCF
-- COO
-- DEBSZ
-- OCLCO
-- EBLCP
-- DEBBG
042 ## - AUTHENTICATION CODE
Authentication code pcc
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.C5
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 771.4
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/4061
Edition number 23
245 02 - TITLE STATEMENT
Title A practical guide to designing phase II trials in oncology /
Statement of responsibility, etc. [edited by] Sarah R. Brown, Walter M. Gregory, Christopher Twelves, Julia Brown.
Medium [electronic resource]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Chichester, West Sussex :
Name of producer, publisher, distributor, manufacturer John Wiley & Sons Inc.,
Date of production, publication, distribution, manufacture, or copyright notice 2014.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Statistics in practice
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc. "Choosing Your Phase II Trial Design provides an overview to clinical trial researchers of the steps involved in designing a phase II trial and provides a way to identify a range of optimal designs. Providing a practical guide containing the information needed to make crucial decisions regarding phase II trial designs, it sets forth specific points for consideration between the statistician and clinician when designing a phase II trial, including issues such as how the treatment works, choice of outcome measure and randomisation. A detailed library of trial designs is featured along with examples and case studies accompanied by illustrations using a flow diagram, highlighting the choices made for each key point throughout the process. For those new to trial design, the book provides an introduction to the concepts behind informed decision making in phase II trials, offering a unique and practical learning tool. For those familiar with phase II trial design, the reader will benefit from exposure to new, less familiar trial designs, providing alternative options to those which the reader may not have previously used"--Provided by publisher.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record and CIP data provided by publisher.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical Trials, Phase II as Topic.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antineoplastic Agents
General subdivision therapeutic use.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drug Evaluation
General subdivision methods.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision drug therapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical trials.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antineoplastic agents
General subdivision Therapeutic use.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumors
General subdivision Treatment.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element HEALTH & FITNESS
General subdivision Diseases
-- General.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Clinical Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Diseases.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Evidence-Based Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Internal Medicine.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antineoplastic agents
General subdivision Therapeutic use.
Source of heading or term fast
Authority record control number (OCoLC)fst00810609
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical trials.
Source of heading or term fast
Authority record control number (OCoLC)fst00864429
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumors
General subdivision Treatment.
Source of heading or term fast
Authority record control number (OCoLC)fst01158791
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Clinical Trials, Phase II as Topic.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
655 #0 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brown, Sarah R.,
Relator term editor of compilation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gregory, Walter M.,
Relator term editor of compilation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Twelves, Chris,
Relator term editor of compilation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brown, Julia
Fuller form of name (Julia M.),
Relator term editor of compilation.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Practical guide to designing phase II trials in oncology
Place, publisher, and date of publication Chichester, West Sussex : John Wiley & Sons Inc., 2014
International Standard Book Number 9781118570906
Record control number (DLC) 2013041156
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Statistics in practice.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://onlinelibrary.wiley.com/book/10.1002/9781118763612
Public note Wiley Online Library
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Books

No items available.

Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login